The drug is approved for certain types of breast cancer, but has failed to show benefit in other types of cancer
Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
At the same time, the relationship appears highly complex and influenced by overall diet, gut microbiome composition, metabolic health, and lifestyle
After the initial three months, long-term side effects are uncommon
Stopping GLP-1 weight-loss drugs triggers sharp metabolic rebound, study warns The largest analysis yet shows why coming off popular obesity and diabetes drugs may undo hard-won gains
Isolating specific genes associated with successful weight loss using these drugs could also be the first steps toward personalized treatments for obesity, Griebeler said